PNEUMOCOCCAL IMMUNIZATION
Clinical trials for PNEUMOCOCCAL IMMUNIZATION explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCOCCAL IMMUNIZATION trials appear
Sign up with your email to follow new studies for PNEUMOCOCCAL IMMUNIZATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New vaccine for babies aims to protect against more pneumonia strains
⭐️ VACCINE ⭐️ Recruiting nowThis study is testing the safety of a new vaccine designed to protect infants and toddlers against 21 strains of pneumococcal bacteria, which can cause pneumonia, meningitis, and ear infections. It will compare the new vaccine's safety to an already approved vaccine that protects…
Matched conditions: PNEUMOCOCCAL IMMUNIZATION
Phase: PHASE3 • Sponsor: Sanofi • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 02, 2026 14:57 UTC
-
New shot for babies aims to block more pneumonia strains
⭐️ VACCINE ⭐️ Recruiting nowThis study is testing a new version of a vaccine that protects against serious bacterial infections like pneumonia and meningitis. It will compare the safety and immune response of the new 21-strain vaccine against a currently licensed 20-strain vaccine in healthy infants. Babies…
Matched conditions: PNEUMOCOCCAL IMMUNIZATION
Phase: PHASE3 • Sponsor: Sanofi • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:29 UTC
-
Pfizer tracks Real-World vaccine safety in korean population
Knowledge-focused Recruiting nowThis study aims to monitor the safety of the Prevenar 20 pneumococcal vaccine in routine medical practice in Korea. It will enroll 660 participants aged 6 weeks and older who receive the vaccine as part of their normal healthcare. Researchers will track any side effects or reacti…
Matched conditions: PNEUMOCOCCAL IMMUNIZATION
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC